NovAseptic was founded in Sweden in 1993 and has been part of Merck Millipore since 2005. With their wide range of mixers, valves and connectors for the pharmaceutical and biotechnology industry, product safety, quality, strength and purity are improved.
NovAseptic mixers, valves and connectors have a reliable and proven aseptic performance in the pharmaceutical and biotechnology industries.
The Life Science business of Merck KGaA, Darmstadt, Germany, operating as MilliporeSigma in the US and Canada, has around 22,000 employees and 59 production sites worldwide with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services.
Merck KGaA completed its acquisition of Sigma-Aldrich in November 2015, gaining a leading role in the global life science industry.
Merck KGaA, a leading science and technology company, operates across healthcare, life science and performance materials. Around 58,000 employees work to make a positive difference to the lives of millions of people every day by creating more life-affirming and sustainable ways of living. From advancing genetic engineering and discovering unique ways to treat the most challenging diseases to enabling device intelligence, the company is everywhere.
In 2019, Merck KGaA had sales of € 16.2 billion in 66 countries. The company holds the global rights to the name and trademark "Merck" internationally. The only exceptions are the USA and Canada, where the business sectors Merck KGaA, Darmstadt, Germany operates as EMD Serono in the healthcare sector, MilliporeSigma in life science and EMD Performance Materials.
Since its founding in 1668, scientific research and responsible entrepreneurship have been key to the company's technological and scientific progress. To this day, the founding family remains the majority owner of the listed company.
